Luminal and TNBC subtypes of breast cancer are highly divergent and have several molecular differences that could contribute to distinct responses to CDK4/6i, including RB status, p53 status, and differential expression of G1 proteins (14, 69, 70, 71, 72). This evidence concerns the gene TP53 and breast cancer.